Skip to main content

Axon Enterprise Eliminates Remaining Convertible Notes, Streamlining Capital Structure

Tipranks - Sat Feb 14, 3:46PM CST

Valentine's Day Sale - 70% Off

Axon Enterprise ( (AXON) ) has issued an update.

Axon Enterprise, Inc. redeemed $840,000 in principal of its 0.50% convertible senior notes due 2027 on February 10, 2026, paying cash equal to 100% of principal plus accrued interest. On February 11, 2026, the company also settled conversions of $80.27 million in principal of these notes, delivering about $80.3 million in cash and 211,870 shares, and received 41,139 shares from option counterparties under existing hedges.

Following these redemptions and conversions, no convertible notes remain outstanding, simplifying Axon’s capital structure and eliminating future obligations related to this debt. The moves indicate a completed transition away from this convertible financing, which may reduce potential future equity dilution for existing shareholders and clarify the company’s balance sheet profile.

The most recent analyst rating on (AXON) stock is a Buy with a $860.00 price target. To see the full list of analyst forecasts on Axon Enterprise stock, see the AXON Stock Forecast page.

Spark’s Take on AXON Stock

According to Spark, TipRanks’ AI Analyst, AXON is a Neutral.

Axon’s overall score is driven by strong earnings call results and growth potential, but is weighed down by technical analysis indicating bearish momentum and high valuation concerns. Financial performance shows growth but highlights risks in profitability and cash flow management.

To see Spark’s full report on AXON stock, click here.

More about Axon Enterprise

Axon Enterprise, Inc. is a technology company that develops and sells public safety products and services, including conducted energy weapons and body-worn cameras, with a focus on law enforcement and related security markets.

Average Trading Volume: 884,256

Technical Sentiment Signal: Sell

Current Market Cap: $34.28B

Learn more about AXON stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.